MYD88 and neoplasm: By employing an integrative approach that harnesses the power of bulk RNA sequencing (RNA-seq) and single-cell RNA sequencing (scRNA-seq), we intend to delineate the molecular underpinnings of MyD88's influence and to chart its interactions with the tumor microenvironment, particularly immune cell infiltration.